Systematic Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Systematic Financial Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-88,232	Closed	-$5.16M	–	643
2016 Q4	$5.16M	Buy	+88,232	New	+$4.82M	0.08%	267
2015 Q3	–	Sell	-168,781	Closed	-$11.2M	–	644
2015 Q2	$11.2M	Sell	168,781 -26,612	-14%	-$1.75M	0.1%	226
2015 Q1	$12.6M	Sell	195,393 -11,315	-5%	-$708K	0.1%	233
2014 Q4	$12.2M	Buy	206,708 +14,980	+8%	+$845K	0.09%	238
2014 Q3	$9.81M	Sell	191,728 -4,493	-2%	-$224K	0.07%	277
2014 Q2	$9.52M	Buy	+196,221	New	+$9.67M	0.07%	290

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Systematic Financial Management's BMY Position: Q1 2017 in Review

Systematic Financial Management sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 88,232 shares — an estimated $5.16M sold.

Systematic Financial Management first reported a position in BMY in Q2 2014 and held it in 6 quarters. The position peaked at $12.6M in Q1 2015. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

Systematic Financial Management reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
Systematic Financial Management sold 88,232 Bristol-Myers Squibb shares in Q1 2017, an estimated $5.16M.
Systematic Financial Management first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 6 quarters.
Systematic Financial Management's Bristol-Myers Squibb position peaked at $12.6M in Q1 2015.
1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Systematic Financial Management's 13F filing for Q1 2017, filed 11 May 2017.